Work

Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myeloma

Year: 1983

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Journal of Cancer and Clinical Oncology

DOI: 10.1016/0277-5379(83)90113-x

Authors: A. Åhre, M. Björkholm, H. Mellstedt, G. Holm, G. Brenning, L. Engstedt, G. Gahrton, J. Hällen, B. Johansson, S.G.O. Johansson, L. Karnström, A. Killander, R. Lerner, D. Lockner, B. Lönnqvist, B. Simonsson, A.-M. Stalfelt, B. Ternstedt, B. Wadman

Institutions: Danderyds sjukhus, Karolinska University Hospital, Uppsala University Hospital, Stockholm South General Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2149406795

FWCI: 1.979

Cites: 24

Cited by: 28

Related to: 10